FDA
approval
· 2024-03-28
FDA Approved: AUROVELA FE 1/20 — Supplemental Application (Aurobindo Pharma Limited)
Summary
The FDA approved a supplemental application for AUROVELA FE 1/20, a generic combined oral contraceptive containing norethindrone acetate, ethinyl estradiol, and…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AUROVELA FE 1/20 (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE)